Mylan enters settlement agreement with Forest Laboratories, Merz Pharmaceuticals for Namenda
Links shared publicly online about this topic.
- 1,004total visits
Mylan enters settlement agreement with Forest Laboratories, Merz Pharmaceuticals for Namenda
Mylan Inc. today announced that it has entered into settlement and license agreements with Forest Laboratories and Merz Pharmaceuticals related to Namenda® Tablets, 5 mg and 10 mg, known generically as Memantine Hydrochloride (HCl) Tablets.
View full resource at news-medical.net
Tags: Alzheimer's Disease Medication, Pharma, Namenda, Axura, Forest Laboratories
Most Recently Shared on July 22, 2010 at 12:52 pm By:
Mylan enters settlement agreement with Forest Laboratories, Merz Pharmaceuticals for Namenda: Mylan Inc. today ann... http://bit.ly/94KNXf
Advertisement
